Document Detail


Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours.
MedLine Citation:
PMID:  20399885     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the present study, we investigated the response of A549 (non-small cell lung-cancer), HepG2 (human hepatoma) and MCF-7 (human breast adenocarcinoma) cell lines to treatment with aclarubicin (ACL). The aim of this research was to compare the ability of ACL to induce apoptosis or necrosis in solid tumours. The mode of cell death induced by ACL was evaluated by flow-cytometry and fluorescence microscopy. We show that the drug induced both apoptosis and necrosis in the cells. Apoptotic cell death was associated with morphological changes, DNA fragmentation, changes in activity of poly(ADP-ribose)polymerase (PARP) and drug-mediated activation of caspase-3 and caspase-8. The occurrence of all these events was time-dependent. The extent of apoptosis was also dependent on the kind of cell line, the sensitivity to ACL and the intracellular drug content. This study demonstrates that the cells most sensitive to ACL, A549, accumulated a significantly higher level of the drug and were also more susceptible to apoptosis than the other cells. In contrast, the relatively less sensitive HepG2 and MCF-7 cell lines appeared more resistant to apoptosis induction. On the basis of these results, it seems that aclarubicin is able to induce apoptosis in human solid tumours.
Authors:
Aneta Rogalska; Marzena Szwed; Zofia Jóźwiak
Related Documents :
10471325 - Poly(adp-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents o...
10772815 - Adenovirus-mediated transfer of caspase-3 with fas ligand induces drastic apoptosis in ...
16170665 - Invasion-associated mmp-2 and mmp-9 are up-regulated intracellularly in concert with ap...
19557855 - Novel quinolone chm-1 induces apoptosis and inhibits metastasis in a human osterogenic ...
19568915 - Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing l...
19708075 - Characterization of the in vitro macrophage response and in vivo host response to poly(...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-24
Journal Detail:
Title:  Mutation research     Volume:  700     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-15     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1-10     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier B.V. All rights reserved.
Affiliation:
Department of Thermobiology, University of Lodz, Banacha 12/16 st., 90-237 Lodz, Poland. zychan@biol.uni.lodz.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aclarubicin / metabolism,  pharmacology*
Antibiotics, Antineoplastic / pharmacology*
Apoptosis / drug effects*
Caspase 3 / metabolism
Caspase 8 / metabolism
DNA Fragmentation / drug effects
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Humans
In Situ Nick-End Labeling
Necrosis / chemically induced*
Poly(ADP-ribose) Polymerases
Time Factors
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 57576-44-0/Aclarubicin; EC 2.4.2.30/Poly(ADP-ribose) Polymerases; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 8

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cellular functions of transient receptor potential channels.
Next Document:  Genotoxicity/mutagenicity of Formaldehyde Revealed by the Arabidopsis thaliana Plants Transgenic for...